Article
Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
21 Jul 2023
Abstract excerpt
BACKGROUND: Alzheimer's disease (AD) has been associated with immune dysregulation in biomarker and genome-wide association studies (GWAS). GWAS hits include the genes encoding complement regulators clusterin (CLU) and complement receptor 1 (CR1), recognised as key players in AD pathology, and complement proteins have been proposed as biomarkers. MAIN BODY: To address whether changes in plasma complement protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
